SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950123-10-112599
Filing Date
2010-12-10
Accepted
2010-12-10 06:00:48
Documents
3
Group Members
HABIB KAIROUZJOSHUA RUCHMARK LESCHLYRHO CAPITAL PARTNERS INC.RHO CAPITAL PARTNERS VERWALTUNGS GMBHRHO MANAGEMENT TRUST IRHO MANAGEMENT VENTURES IV LLCRHO VENTURES IV GMBH & CO BETEILIGUNGS KGRHO VENTURES IV LPRHO VENTURES IV QP LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D c09527sc13d.htm SC 13D 201909
2 EXHIBIT B c09527exv99wb.htm EX-99.B 17093
3 EXHIBIT C c09527exv99wc.htm EX-99.C 7586
  Complete submission text file 0000950123-10-112599.txt   228977
Mailing Address 152 WEST 57TH STREET 23RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 23RD FLOOR NEW YORK NY 10019 2127516677
RHO CAPITAL PARTNERS INC (Filed by) CIK: 0001020455 (see all company filings)

IRS No.: 133087622 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals Inc (Subject) CIK: 0001411158 (see all company filings)

IRS No.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85788 | Film No.: 101243586
SIC: 2834 Pharmaceutical Preparations